# A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

> **NCT01001234** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1382 (actual)

## Conditions studied

- Migraine, Acute

## Interventions

- **DRUG:** rizatriptan
- **DRUG:** placebo
- **DRUG:** rizatriptan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01001234
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-30
- **Primary completion:** 2011-04-21
- **Final completion:** 2011-04-21
- **Target enrollment:** 1382 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001234, "A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01001234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*